Azenta Q3 2024 Earnings Conference Call Results

Azenta Life Sciences reported Q3 2024 results for the quarter ended June 30, 2024, with revenue of $173M (up 4% YoY) and a return to profitability with non-GAAP EPS of $0.16. The company achieved 260 basis points of adjusted EBITDA margin expansion year-over-year and returned $226M in capital via share repurchases. Strong balance sheet with $754M in cash supported disciplined long-term value creation initiatives.